title: Ischemia-Modified Albumin is not Elevated in Deep Venous Thrombosis.
abstract: BACKGROUND
  In this article, we aimed to determine the diagnostic role of ischemia-modified albumin (IMA) in the evaluation of patients with deep venous thrombosis (DVT).
  
  
  METHODS
  Fifty-five patients with a diagnosis of DVT and 47 healthy subjects as the control group were included in the study. Blood samples of the patients were obtained within the first 24 hours after DVT diagnosis for IMA analysis. Patient and control groups were compared with respect to IMA levels.
  
  
  RESULTS
  We found that HDL and albumin levels were significantly higher in the control group. However, we could not determine a significant increase in IMA levels in patients with DVT when compared to the control group.
  
  
  CONCLUSIONS
  Our study revealed that IMA is not a useful marker in the diagnosis of DVT.
authors.forename: Emrah
authors.initials: E
authors.lastname: Ereren
authors.forename: Ali Kemal
authors.initials: AK
authors.lastname: Erenler
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Karavelioğlu
authors.forename: Ramazan
authors.initials: R
authors.lastname: Kocabaş
authors.forename: Haci Kemal
authors.initials: HK
authors.lastname: Erdemli
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012709:Serum Albumin; D000075462:Serum Albumin, Human; D020246:Venous Thrombosis / Q000097:blood*
chemical_list: D015415:Biomarkers; D012709:Serum Albumin; C561522:ischemia-modified albumin; D000075462:Serum Albumin, Human